Sk Biopharmaceuticals Co Ltd Free Cash Flow Generation Index

Latest as of March 2026: 0.84x

Sk Biopharmaceuticals Co Ltd free cash flow generation index. Sk Biopharmaceuticals Co Ltd (326030) has a Free Cash Flow Generation Index of 0.84x as of March 2026. Free cash flow of ₩14.97 Billion represents 1% of operating cash flow (₩17.92 Billion). Check Sk Biopharmaceuticals Co Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.

FCF Generation Index

0.84x

Free Cash Flow / Operating CF

Free Cash Flow

₩14.97 Billion

KRW

Operating Cash Flow

₩17.92 Billion

KRW

Capital Expenditures

₩2.94 Billion

KRW

Free Cash Flow Generation Index of Sk Biopharmaceuticals Co Ltd (2024–2025)

Free cash flow generation index of Sk Biopharmaceuticals Co Ltd from 2024 to 2025. Historical FCF Generation Index trend for Sk Biopharmaceuticals Co Ltd across 2 annual periods. Explore 326030 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.

Sk Biopharmaceuticals Co Ltd Free Cash Flow Generation Index by Year (2024–2025)

Sk Biopharmaceuticals Co Ltd free cash flow generation index by year from 2024 to 2025. Year-by-year Free Cash Flow Generation Index for Sk Biopharmaceuticals Co Ltd. For the full cash flow conversion analysis, see Sk Biopharmaceuticals Co Ltd (326030) cash flow conversion.

Year	FCG Index	Free Cash Flow (KRW)	Operating CF	Capital Expenditures	YoY Change
2025	0.83x	₩146.82 Billion	₩176.33 Billion	₩29.51 Billion	▼ -3.0%
2024	0.86x	₩81.48 Billion	₩94.90 Billion	₩13.42 Billion	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).